Do We Expect Any Pleiotropic Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibition for Reducing Cardiovascular Events Beyond Low-Density Lipoprotein Cholesterol Reduction?
Circulation Journal - Japan
doi 10.1253/circj.cj-17-0586
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2017
Authors
Publisher
Japanese Circulation Society